Innovative drug Glutargin, the leader of domestic hepatology, has been deservedly approved not only by the Ukrainian medical community. Glutargin received recognition of its effectiveness in the authoritative German edition for gastroenterologists.

European founders who purchased shares of Pharmaceutical Company «Zdorovye» set the goal of bringing it to the European market.